BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23452641)

  • 1. A clinicopathological and immunohistochemical study of minimal deviation adenocarcinoma of the uterine cervix.
    Zhu L; Yi X; Lin B; Gao A; Zhao W; Zhang Y; Li Y
    Med Hypotheses; 2013 May; 80(5):643-8. PubMed ID: 23452641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of minimal deviation adenocarcinoma of the cervix: a report of five cases].
    Chang J; Zhang S; Zhou H; Liang JX; Lin ZQ
    Ai Zheng; 2008 Dec; 27(12):1310-4. PubMed ID: 19080000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix.
    Simionescu C; Georgescu CV; Mărgăritescu C; Niculescu M
    Rom J Morphol Embryol; 2006; 47(3):245-9. PubMed ID: 17308683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimal deviation endocervical adenocarcinoma--clinical, histologic and immunohistochemical study].
    Zhang JM
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):275-7. PubMed ID: 2625109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions.
    Michael H; Grawe L; Kraus FT
    Int J Gynecol Pathol; 1984; 3(3):261-76. PubMed ID: 6500801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
    Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
    Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
    Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
    Mikami Y; Kiyokawa T; Moriya T; Sasano H
    Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological study on minimal deviation adenocarcinoma of uterine cervix].
    Yao X; Peng Z; Yang K
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):401-3. PubMed ID: 12485479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
    Barbu I; Crăiţoiu S; Mărgăritescu C
    Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.
    Gilks CB; Young RH; Aguirre P; DeLellis RA; Scully RE
    Am J Surg Pathol; 1989 Sep; 13(9):717-29. PubMed ID: 2764221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological and histochemical study of adenoma malignum of the uterine cervix].
    Sasaki A
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Apr; 44(4):427-32. PubMed ID: 1607772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoplastic stromal response as defined by positive α-smooth muscle actin staining is predictive of invasion in adenocarcinoma of the uterine cervix.
    Jordan SM; Watanabe T; Osann K; Monk BJ; Lin F; Rutgers JK
    Int J Gynecol Pathol; 2012 Jul; 31(4):369-76. PubMed ID: 22653352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
    Lu X; Toki T; Konishi I; Nikaido T; Fujii S
    Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.